Bergamaschi, R.; Capobianco , M.; Ravasio, R. Budget Impact Analysis of Natalizumab Biosimilar on Pharmaceutical Expenditure for the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy. AboutOpen 2024, 11, 48-56.